Myomo Raises FY2026 Sales Guidance from $43.000M-$46.000M to $45.000M-$47.000M vs $44.434M Est

Benzinga Newsdesk www.benzinga.com Positive 94.2%

Neg 0% Neu 0% Pos 94.2%

Myomo (AMEX:MYO) raises FY2026 sales outlook from $43.000 million-$46.000 million to $45.000 million-$47.000 million vs $44.434 million estimate.